I imagine we’ve all been closely following the Ebola outbreak in Africa. Although we’re a long way from the finish line, how encouraging is it that a very experimental biotech drug may be saving the lives of a couple of infected healthcare workers.
Moving toward the integrated display of a glucose monitoring system, and insulin pump system for diabetes (Dexcom and Insulet).
Will animal testing eventually go the way of the dodo bird in drug development? Maybe – now that scientists are developing “human body on a chip” technology. Fascinating stuff.
Big investment money going after CARTs (leading-edge cancer treatment based on re-engineering the patient’s own white blood cells).
Alliance between BMS and Allied Minds to speed R&D developments in university research insititutions (data-, expertise-, and resource-sharing).
Novartis on the threshold of a new chronic heart failure treatment.
BONUS: will there soon be a blood test to detect ANY type of cancer?
Leave a Reply